Study of Sivelestat Sodium in OPCABG

NCT07118930 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease
Coronary Artery Disease
Coronary Arterial Disease (CAD)

Interventions

DRUG: Sivelestat Sodium injection 2 h after OPCABG for 72 h
DRUG: Saline (0.9% NaCl)

Sponsor

Affiliated Hospital of Nantong University